Skip to content

Clodronate Liposome effectively Mitigates Chemically-Induced Retinal Pigment Epithelium Toxicity.

Aug 2026 · Experimental Eye Research · Vol 272, pp. 111202 · 0 citations · 67 references
Medicine

TL;DR

It is suggested that clodronate liposomes exert model-dependent protection, likely through modulation of peripheral macrophage-mediated RPE toxicity following chemical exposure, likely through modulation of peripheral macrophage-mediated RPE toxicity following chemical exposure.

Abstract

Visual impairment resulting from accidental chemical exposure is commonly encountered in emergency medicine, yet effective clinical interventions remain lacking. Given the critical roles of both resident microglia and peripheral macrophages in retinal degenerative diseases, this study systematically evaluated the protective effects of minocycline, PLX3397, and clodronate liposomes in sodium iodate (NaIO3)- and N-methyl-N-nitrosourea (MNU)-induced retinal degeneration models. Suppression of microglial activation with minocycline or depletion of resident microglia with PLX3397 failed to ameliorate retinal damage in either model, as evidenced by persistent fundus atrophy, diminished electroretinogram responses, and robust photoreceptor apoptosis. In contrast, systemic depletion of peripheral macrophages using clodronate liposomes significantly alleviated fundus atrophy, partially preserved visual function, and increased photoreceptor and retinal pigment epithelium (RPE) survival in the NaIO3 model, but conferred no protection in the MNU model. These findings suggest that clodronate liposomes exert model-dependent protection, likely through modulation of peripheral macrophage-mediated RPE toxicity following chemical exposure.

View source

Similar papers

Open access Sep 2026

Targeting prostaglandin catabolism via topical nanotherapy rescues vision in ischemic optic neuropathy

These findings establish 15-PGDH–mediated prostaglandin catabolism as a therapeutic target in ischemic optic neuropathy and demonstrate a clinically translatable nanotherapeutic strategy for protecting the central nervous system from ischemic neurodegeneration.

Shweta Modgil, Rusiou Hsu, M. Shariati et al. · 0 citations
Open access Aug 2026

Cynarin Alleviates Sodium Iodate-Induced Retinal Pigment Epithelium Injury by Regulating Oxidative Stress and Inflammation

Cynarin protects against oxidative stress-induced retinal degeneration by suppressing MAPK and NF-κB inflammatory signaling, representing a promising therapeutic candidate for preventing or delaying NaIO3-induced dry AMD-like retinal injury.

Yue-Lin Fang, Y. Hsu, Chao-Hsien Sung et al. · 0 citations
Review Open access Aug 2026

Iontophoresis Drug Delivery to the Macula of Lutein for Age Related Macular Degeneration

The capacity of TSI to deliver lutein inside the retina, overcoming physiological barriers that may limit the efficacy of lutein oral administration is highlighted, overcoming physiological barriers that may limit the efficacy of lutein oral administration.

M. L. Salvetat, Francesco Pellegrini, Marco Zeppieri et al. · 0 citations
Sep 2026

Andrographolide-loaded PLGA nanoparticles protect retinal ganglion cells against experimental acute glaucomatous injury and attenuate mitochondrial dysfunction and retinal PANoptosis-related changes.

Developed ADR-loaded poly(lactic-co-glycolic acid) nanoparticles (ADR-NPs) and evaluated their protective effects in oxygen-glucose deprivation/recovery (OGD/R)-injured R28 cells and a rat retinal ischemia/reperfusion (RIR) model protected against experimental acute glaucomatous injury by attenuating oxidative stress,...

Xiao Fan, Ruo-Tong Ouyang, Yu-Jia Huo et al. · 0 citations
Review Open access Sep 2026

Ferroptosis in retinal neurodegeneration: mechanistic vulnerability, therapeutic targeting, and translational barriers

Current evidence supporting ferroptosis-related vulnerability in retinal neurodegenerative diseases is synthesized and emerging enabling strategies are evaluated, including nanocarrier-based delivery, long-acting gene modulation, and biomarker frameworks integrating ocular fluids, imaging, multi-omics, and artificial i...

Guang-Guang Wu, Su-Yu Wang, Zi-Yi Chen et al. · 0 citations
Review Open access Sep 2026

Nanoparticle-Mediated Lutein Delivery for Diabetic Retinopathy: From Blood-Retinal Barrier Crossing to Neurovascular Unit Protection

Abstract Diabetic retinopathy (DR) is increasingly understood as an integrated neurovascular unit (NVU) pathology driven by chronic hyperglycemia, rather than solely a microvascular complication. Anti-vascular endothelial growth factor (anti-VEGF) therapy remains limited by repeated intravitreal injections, treatment r...

Ya-Nan Wang, Wen-Fang Xu, Yong-Gen Xu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.